Want to see HK:1112 full AI Analyst Report?
1112 Stock Chart & Stats
HK$14.58
-HK$0.20(-1.37%)
At close: 4:00 PM EDT
HK$14.58
-HK$0.20(-1.37%)
Day’s Range― - ―
52-Week RangeHK$10.10 - HK$16.80
Previous CloseN/A
Volume1.46M
Average Volume (3M)2.14M
Market Cap
HK$9.81B
Enterprise ValueHK$16.63K
Total Cash (Recent Filing)HK$1.73B
Total Debt (Recent Filing)HK$9.06B
Price to Earnings (P/E)43.5
Beta0.86
Next Earnings
Aug 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.3%
Share Statistics
EPS (TTM)0.30
Shares Outstanding645,561,340
10 Day Avg. Volume985,367
30 Day Avg. Volume2,140,320
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.26
Price to Sales (P/S)0.53
P/FCF Ratio7.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$19.82Price Target Upside35.94% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)1.27
Revenue Forecast (FY)HK$16.48B
Bulls Say, Bears Say
Bulls Say
High Gross MarginsGross margins near 60–64% provide durable unit economics that cushion the P&L against input cost swings and support marketing and channel investment. Over 2–6 months this margin base helps sustain operating leverage even if revenue growth moderates.
Consistent Positive Free Cash FlowSizable, recurring free cash flow (~HK$0.95B in 2025) underpins the company’s ability to service obligations, fund working capital, and invest in brands. Even with slower FCF growth, persistent cash generation strengthens resilience and strategic optionality.
Multi-channel Brand DistributionA diversified go-to-market model (own e-commerce, marketplaces, pharmacies, retailers, distributors) reduces single-channel risk, broadens reach across consumer segments and geographies, and supports scale advantages in marketing and shelf presence over time.
Bears Say
Elevated LeveragePersistent debt-to-equity near 1.5 limits financial flexibility and raises refinancing and interest-rate vulnerability. With leverage elevated, the company has less buffer to absorb profit shocks or fund expansion without increasing risk or slowing deleveraging over multiple quarters.
Volatile ProfitabilityEarnings swung to a loss in 2024 and recovered only to a thin net margin of ~1.4% in 2025, indicating unstable core profitability. This variability undermines cash-flow predictability and makes capital allocation and long-term planning more difficult for management.
Weak Cash Coverage & Declining FCFA meaningful FCF decline and operating cash flow coverage of about 0.22 versus debt imply slow deleveraging capacity. That low coverage limits the pace of balance-sheet repair and constrains room for incremental investment or larger strategic M&A without raising leverage.
Health and Happiness (H&H) International Holdings News
1112 FAQ
What was Health and Happiness (H&H) International Holdings Limited’s price range in the past 12 months?
Health and Happiness (H&H) International Holdings Limited lowest stock price was HK$10.10 and its highest was HK$16.80 in the past 12 months.
What is Health and Happiness (H&H) International Holdings Limited’s market cap?
Health and Happiness (H&H) International Holdings Limited’s market cap is HK$9.81B.
When is Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date?
Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date is Aug 25, 2026 which is in 22 days.
How were Health and Happiness (H&H) International Holdings Limited’s earnings last quarter?
Health and Happiness (H&H) International Holdings Limited released its earnings results on Mar 24, 2026. The company reported HK$0.212 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Health and Happiness (H&H) International Holdings Limited overvalued?
According to Wall Street analysts Health and Happiness (H&H) International Holdings Limited’s price is currently Undervalued.
Does Health and Happiness (H&H) International Holdings Limited pay dividends?
Health and Happiness (H&H) International Holdings Limited pays a Semiannually dividend of HK$0.16 which represents an annual dividend yield of 2.3%. See more information on Health and Happiness (H&H) International Holdings Limited dividends here
What is Health and Happiness (H&H) International Holdings Limited’s EPS estimate?
Health and Happiness (H&H) International Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Health and Happiness (H&H) International Holdings Limited have?
Health and Happiness (H&H) International Holdings Limited has 645,561,340 shares outstanding.
What happened to Health and Happiness (H&H) International Holdings Limited’s price movement after its last earnings report?
Health and Happiness (H&H) International Holdings Limited reported an EPS of HK$0.212 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.782%.
Which hedge fund is a major shareholder of Health and Happiness (H&H) International Holdings Limited?
Currently, no hedge funds are holding shares in HK:1112
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Health and Happiness (H&H) International Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.69%
12-Months-Change
Fundamentals
Return on Equity
2.30%
Trailing 12-Months
Asset Growth
7.56%
Trailing 12-Months
Company Description
Health and Happiness (H&H) International Holdings Limited
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
Health and Happiness (H&H) International Holdings (1112) Earnings & Revenues
1112 Company Deck
1112 Earnings Call
Q4 2026
0:00 / 0:00
1112 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
HK$19.82
▲(35.94% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Want Want China Holdings
―
China Mengniu Dairy Co
―
Vitasoy International Holdings
―
Ausnutria Dairy Corp. Ltd.
―
China Feihe Limited
―






